IN2015CH04438A - - Google Patents
Download PDFInfo
- Publication number
- IN2015CH04438A IN2015CH04438A IN4438CH2015A IN2015CH04438A IN 2015CH04438 A IN2015CH04438 A IN 2015CH04438A IN 4438CH2015 A IN4438CH2015 A IN 4438CH2015A IN 2015CH04438 A IN2015CH04438 A IN 2015CH04438A
- Authority
- IN
- India
- Prior art keywords
- peptides
- peptide
- sequence
- vaxijen
- snaqknqgnc
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- 241000589902 Leptospira Species 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- 238000002887 multiple sequence alignment Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4438CH2015 IN2015CH04438A (enExample) | 2015-08-24 | 2015-08-24 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4438CH2015 IN2015CH04438A (enExample) | 2015-08-24 | 2015-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015CH04438A true IN2015CH04438A (enExample) | 2015-09-25 |
Family
ID=54398292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4438CH2015 IN2015CH04438A (enExample) | 2015-08-24 | 2015-08-24 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2015CH04438A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024187254A1 (pt) | 2023-03-10 | 2024-09-19 | Instituto Butantan | Proteína quimérica, célula microbiana hospedeira, processo de obtenção da referida proteína quimérica, kit de diagnóstico sorológico da leptospirose, método in vitro de diagnóstico sorológico precoce da leptospirose e uso da referida proteína quimérica |
-
2015
- 2015-08-24 IN IN4438CH2015 patent/IN2015CH04438A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024187254A1 (pt) | 2023-03-10 | 2024-09-19 | Instituto Butantan | Proteína quimérica, célula microbiana hospedeira, processo de obtenção da referida proteína quimérica, kit de diagnóstico sorológico da leptospirose, método in vitro de diagnóstico sorológico precoce da leptospirose e uso da referida proteína quimérica |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500707A1 (en) | Anti-human cd19 antibodies with high affinity | |
| MX371187B (es) | Péptidos terapéuticos. | |
| PH12017500915A1 (en) | Cd47 antibodies, methods, and uses | |
| MX2018002831A (es) | Polipeptidos. | |
| PH12016501937A1 (en) | Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage | |
| TN2018000276A1 (en) | Inhibitors of receptor-interacting protein kinase 1. | |
| NZ731571A (en) | T cell receptors | |
| SG10201902924RA (en) | Antibodies that bind ebola glycoprotein and uses thereof | |
| JO3092B1 (ar) | مركب لتحفيز مسيطر عليه للمبيض | |
| EA201490039A1 (ru) | Химерные и гибридные полипептиды фактора viii и способы их применения | |
| TR201900360T4 (tr) | Valsartan ve ahu-377 i̇çeren tri̇sodyum çok moleküllü kompleksi̇n kri̇stali̇n formlari ve bunun yöntemleri̇ | |
| NZ726859A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| MX367661B (es) | Anticuerpos anti-baff novedosos. | |
| EA201691363A1 (ru) | Стабилизированные силикатные композиции и их применение в качестве антиперспирантных композиций | |
| MX2017005642A (es) | Anticuerpos anti-angiopoyetina 2 (ang2) y metodos de uso. | |
| ZA201703510B (en) | Antibodies, uses & methods | |
| MY191539A (en) | Streptococcal vaccine | |
| MX2018016121A (es) | Preparacion de anticuerpos monoclonales marcados con 212pb. | |
| IN2014DN09367A (enExample) | ||
| EA201590845A1 (ru) | Варианты fc-гамма-рецептора iib | |
| PH12017500120A1 (en) | Methods of improving myocardial performance in fontan patients using udenafil compositions | |
| MX362058B (es) | Péptido pntx(19) sintético, composición farmacéutica y uso. | |
| PH12016500742A1 (en) | Novel peptide having 4 linked ctl epitopes | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| EA201690966A1 (ru) | Новое соединение для лечения тяжелой гипогликемии |